NDC 51655-383 – Glimepiride
Glimepiride 2 mg/1 · Tablet · Oral
Product NDC51655-383
Product details
- Brand name
- Glimepiride
- Generic name
- Glimepiride
- Labeler
- Northwind Health Company, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA078181
- Marketed since
- September 7, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Sulfonylurea
Active ingredients
- Glimepiride 2 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 51655-383-26 | 90 TABLET in 1 BOTTLE, PLASTIC (51655-383-26) | Jan 20, 2023 |
| 51655-383-52 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-383-52) | Sep 7, 2022 |
Recalls mentioning this NDC
- D-0551-2023 May 3, 2023 · Class II
CGMP Deviations
Other Glimepiride products
- 50090-6322 Glimepiride 4 mg/1 · Tablet · A-S Medication Solutions
- 50090-6415 Glimepiride 2 mg/1 · Tablet · A-S Medication Solutions
- 50090-6394 Glimepiride 1 mg/1 · Tablet · A-S Medication Solutions
- 50090-7187 Glimepiride 1 mg/1 · Tablet · A-S Medication Solutions
- 50090-1006 Glimepiride 4 mg/1 · Tablet · A-S Medication Solutions
- 50090-6426 Glimepiride 2 mg/1 · Tablet · A-S Medication Solutions
- 50090-7406 Glimepiride 4 mg/1 · Tablet · A-S Medication Solutions
- 50090-7407 Glimepiride 4 mg/1 · Tablet · A-S Medication Solutions
- 50090-6852 Glimepiride 4 mg/1 · Tablet · A-S Medication Solutions
- 50090-6910 Glimepiride 2 mg/1 · Tablet · A-S Medication Solutions
- 50090-7246 Glimepiride 2 mg/1 · Tablet · A-S Medication Solutions
- 50090-7247 Glimepiride 2 mg/1 · Tablet · A-S Medication Solutions